Abstract
The synthesis and biological evaluation of a series of N-alkyl glycine amide analogs as LTA(4)-h inhibitors and the importance of the introduction of a benzoic acid group to the potency and pharmacokinetic parameters of our analogs are described. The lead compound in the series, 4q, has excellent potency and oral bioavailability.
MeSH terms
-
Administration, Oral
-
Amides / chemistry*
-
Amines / chemistry
-
Anti-Inflammatory Agents / pharmacology
-
Benzoic Acid / chemistry
-
Biological Availability
-
Chemistry, Pharmaceutical
-
Drug Design
-
Enzyme Inhibitors / pharmacokinetics*
-
Epoxide Hydrolases / antagonists & inhibitors*
-
Ethers
-
Glycine / chemistry*
-
Inhibitory Concentration 50
-
Models, Chemical
Substances
-
Amides
-
Amines
-
Anti-Inflammatory Agents
-
Enzyme Inhibitors
-
Ethers
-
Benzoic Acid
-
Epoxide Hydrolases
-
Glycine
-
leukotriene A4 hydrolase